Picture of Pila Pharma AB logo

PILA Pila Pharma AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Pila Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Interim ReportInterim ReportPRESSARSARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.98-17.2-26.8-9.93-11.2
Non-Cash Items3.627.9417.94.574.16
Other Non-Cash Items
Changes in Working Capital1.36-0.093-0.2160.502-0.739
Change in Accounts Receivable
Change in Accounts Payable
Change in Other Liabilities
Cash from Operating Activities-2-9.36-9.09-4.85-7.82
Capital Expenditures00000
Purchase of Fixed Assets
Other Investing Cash Flow Items00000
Sale of Fixed Assets
Cash from Investing Activities00000
Financing Cash Flow Items-3.6-7.92-17.9-3.5-3.08
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.15835.7-11.93.566.76
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2.1626.3-21-1.29-1.06